Search Results - Mads Axelsen
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity by John E. Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie Hjerpsted
Published 2017Artigo -
5
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials by Kenneth D Boffard, Bruno Riou, Brian Warren, Peter Choong, Sandro Rizoli, Rolf Rossaint, Mads Axelsen, Yoram Kluger
Published 2005Artigo -
6
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabe... by Vanita R. Aroda, Stephen C. Bain, Bertrand Cariou, Milivoj Piletič, Ludger Rose, Mads Axelsen, Everton Rowe, J. Hans DeVries
Published 2017Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Alternative medicine
Insulin
Liraglutide
Pathology
Placebo
Semaglutide
Clinical endpoint
Randomized controlled trial
Insulin glargine
Metformin
Neuropeptide
Neuropeptide Y receptor
Peptide YY
Receptor
Adverse effect
Anesthesia
Animal science
Appetite
Area under the curve
Basal (medicine)
Biology
Blood transfusion
Blunt
Blunt trauma
Body weight